News and Research
Immune System
Rochester, BCM Test Bird-flu Vaccine In Humans
3-24-2004
Doctors are beginning the first test in the United States
of a vaccine designed to protect people against one form
of bird flu should an outbreak of the virus occur in humans.
While the vaccine under study is not designed to protect
against the precise bird-flu virus causing the current outbreak
in poultry and in people, scientists will learn whether
it protects against another strain of the virus that infects
birds and people.
Physicians
at the University of Rochester and Baylor College of Medicine
(BCM) have embarked on an eight-month study to test an investigational
vaccine in about 200 people. The study is being done at
the request of the National Institute of Allergy and Infectious
Diseases (NIAID), which funds a network of institutions
to test new vaccines against diseases like flu, smallpox,
and pneumonia.
The
study overall is led by Robert L. Atmar, M.D., associate
professor of medicine and molecular virology and microbiology
at BCM. John Treanor, M.D., professor of medicine and director
of Rochester's Vaccine and Treatment Evaluation Unit, is
leading Rochester's portion of the study.
Nurses
and doctors will enroll participants in the study during
the next two months, and then for six months they'll closely
monitor the participants, checking their health and taking
blood tests to check the immune response created by the
vaccine.
While
only about two dozen people worldwide have died in recent
months after becoming infected from a strain of flu known
as H5N1 that is normally found in birds, bird flu is seen
as a potent threat to human health because of its potential
to rip quickly through a human population. A typical flu
virus that normally circulates in humans causes tens of
thousands of deaths each year, even though most people have
some immunity against this "normal" flu. But avian
flu is feared by doctors because hardly anyone carries any
defenses.
|
|
"People generally haven't been exposed to bird
flu viruses and so they have no immunity. A bird flu virus that acquired
the ability to thrive in people could cause a severe epidemic,"
says Treanor.
Indeed, just last month, researchers announced that
the worst flu epidemic on record, the 1918 outbreak of the Spanish
flu, appears to have been caused by a virus that jumped from birds
to humans. That outbreak claimed anywhere from 30 to 40 million lives
worldwide, historians estimate.
During the past few months, millions of chickens and
turkeys, mainly in Asia, have been killed as authorities seek to halt
the spread of a particularly lethal type of bird flu. South Korea,
China, Thailand, Vietnam, Pakistan, Indonesia, Cambodia, Japan, and
the Netherlands are among the nations that have seen outbreaks of
bird flu in chickens and other birds recently. In the United States
there have been outbreaks of bird flu in poultry farms in Maryland,
Texas, New Jersey, Pennsylvania, and Delaware.
While a few people in affected areas have died, the
real danger is if a bird flu virus infects a person who is also infected
with the usual human flu. With some minor genetic modifications, bird
flu could gain the potential to be transmitted from person to person.
While vaccines to protect against normal flu are widely
used every year, there is currently no vaccine approved to protect
against any of the more than a dozen forms of bird flu. The vaccine
that Baylor and Rochester researchers are studying aims to protect
people against a form of the virus, H9, which infected several people
in Hong Kong in 1999. Other researchers are now developing other vaccines
that could protect against the H5 form, which is responsible for most
of the recent deaths in Asia.
"When you're talking about bird flu, you're really
talking about many different viruses," says Treanor. "We
are doing our best to be prepared for as many of them as possible."
This story has been adapted from a news release issued
by University Of Rochester Medical Center, www.urmc.rochester.edu.
Next - Back
to Immune System Support